QTTB: q32bio.com Kompaniya qiymatining sof foydaga nisbati
Q32 Bio Inc. (QTTB) klinik sinovlarga e'tibor qaratgan holda, birlashishlarni amalga oshirmasdan, sog'liqni saqlash gigantlari bilan ittifoqlar orqali o'zining ilmiy salohiyatini kengaytirmoqda. Kompaniyaga tegishli daromadlar og'ir yallig'lanishlar uchun immun javobini tuzatuvchi agentlarni bozorga olib chiqishga asoslanadi. Ushbu grafik 8.40 miqdoridagi joriy bozor bahosini aks ettiradi. Bundan tashqari, biznes buyrak patologiyalarini davolash uchun terapiyalarni yaratish maqsadida komplement tizimini o'rganmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_QTTB_-_Q32-Bio-Inc._-_PE-Multiple "QTTB: Q32 Bio Corp Biznesning o‘zini qoplash muddati 27.03.2024 - 12.11.2026 | 👁️GURU.Markets👁️")
Q32 Bio Inc (QTTB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Q32 Bio Inc.|QTTB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Q32 Bio Corp|QTTB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Q32 Bio Inc.|QTTB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Q32 Bio|Kritik likvidlik q32bio.com
- foyda va bozor multiplikatorlari tafsilotlari:
QTTB - Sof daromad|Kutilayotgan foyda Q32 Bio Inc.|QTTB - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Q32 Bio Corp|QTTB - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Q32 Bio Inc.|QTTB - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Q32 Bio|QTTB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi q32bio.com|QTTB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Q32 Bio Inc.
Kompaniyaning har tomonlama tahlili:q32bio.com QTTB
Emitent ishonchliligini tekshirishda investor bir dollar foydaning tannarxini o'lchash uchun bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadigan kompaniyaning P/E ko'rsatkichidan foydalanadi. 8.40 ning joriy qiymati Q32 Bio Inc. (QTTB) ning fuzion proteinlarini ishlab chiqishga bo'lgan bozor kutuvlarini aks ettiradi, bunda kompaniyaning P/E tendentsiyasi innovatsion immunoterapiya qiymatini biznesning haqiqiy daromad keltirish qobiliyatiga bog'laydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Tourmaline (TRML)|PGEN (Precigen, Inc.) - Narx-foyda koeffitsiyenti|PHAR (pharming.com) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti NKTR|UPB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZBIO|Narxning foydaga nisbati IMNM (Immunome Bio)|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|Biznesning o‘zini qoplash muddati kalvista.com (KALV)|SEPN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT Therapeutics Inc. - Narx-foyda multiplikatori|P/E multiplikatori JBIO (Aerovate Therapeutics)|ACRS - Narx-foyda koeffitsiyenti|KYTX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati tizianalifesciences.com TLSA|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Ventyx Biosciences Inc. VTYX|Narx-foyda koeffitsiyenti THTX|AVTX (Avalo Therapeutics Inc) - Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|Bozor narxining sof foydaga nisbati AGEN|P/E multiplikatori CLYM (Climb Bio)|Zura Bio Ltd - Narxning foydaga nisbati|ATYR - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ADAG|IMA: P/E multiplikatori|Shattuck Labs - Kompaniya qiymatining sof foydaga nisbati|EQ (Equillium Inc) - P/E multiplikatori|P/E multiplikatori Connect Pharma|Narxning foydaga nisbati Immunic, Inc. (IMUX)|ATRA (atarabio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati InflaRx IFRX|XFOR - Narx-foyda koeffitsiyenti|Adicet - P/E multiplikatori|CELU - P/E multiplikatori|INMB (INmune Bio Corp) - Narx-foyda koeffitsiyenti|Barinthus Biotherapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|KZR (Kezar Life Sciences) - P/E multiplikatori|sabbiotherapeutics.com (SABS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Akari Therapeutics Plc (AKTX)|Narx-foyda koeffitsiyenti enlivex.com ENLV|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA - Narx-foyda koeffitsiyenti|IBIO: Narx-foyda koeffitsiyenti|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda multiplikatori BOLT|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aptevo APVO|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|aditxt.com (ADTX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|GRI Bio - Narx-foyda koeffitsiyenti|XORTX Therapeutics Inc - Narxning foydaga nisbati|HIND: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati REVB (Revelation Biosciences Corp)|INDP: P/E multiplikatori|SCNI (scinai.com) - Narxning foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|HOOK - Kapitalizatsiyaning foydaga nisbati|IGM Biosciences - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
